Instituto Oncológico Dr Rosell
5 clinical trials · Sponsor
◉ Watch Instituto Oncológico Dr Rosell
| Record | Firm | Date |
|---|---|---|
| Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma (NCT07251413) | Instituto Oncológico Dr Rosell | 2025-10-22 |
| Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients (NCT04772235) | Instituto Oncológico Dr Rosell | 2022-02-11 |
| Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer (NCT04487756) | Instituto Oncológico Dr Rosell | 2021-03-17 |
| Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge (NCT04537130) | Instituto Oncológico Dr Rosell | 2020-12-01 |
| E GFR TKI and EGF-P TI C Ombination in EGFR mutA nt NSCL C (NCT03623750) | Instituto Oncológico Dr Rosell | 2018-07-06 |
Track Instituto Oncológico Dr Rosell automatically
Every clearance here is in the API, with alerts when new ones post.